Improved Oral Anticoagulation After a Dietary Vitamin K-Guided Strategy A Randomized Controlled Trial

被引:35
|
作者
de Assis, Michelli C. [1 ]
Rabelo, Eneida R. [1 ]
Avila, Christiane W. [1 ]
Polanczyk, Carisi Anne [1 ]
Rohde, Luis E. [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Serv Cardiol,Div Cardiovasc, Postgrad Program Cardiol & Cardiovasc Sci, BR-90035003 Porto Alegre, RS, Brazil
关键词
anticoagulants; diet; vitamin K; INTRACRANIAL HEMORRHAGE; RISK-FACTORS; WARFARIN; SENSITIVITY; SUPPLEMENTATION; VARIABILITY; STABILITY;
D O I
10.1161/CIRCULATIONAHA.109.849208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Dietary vitamin K is thought to be an important factor that interferes with anticoagulation stability, but the clinical applicability of this interaction has not been evaluated adequately in prospective studies. Methods and Results-In a randomized controlled trial that enrolled outpatients with a recent international normalized ratio (INR) outside the therapeutic target, we compared 2 strategies to optimize long-term oral anticoagulation: (1) a conventional approach based on changes in anticoagulant prescription and (2) a dietary vitamin K- guided strategy based on simple modifications of the amount of vitamin K- rich foods ingested per week. The primary efficacy end point was the percentage of patients who achieved a prespecified INR target at 90 days after randomization. Study population (n = 132) predominantly included men with mechanical heart prostheses (58%) or atrial fibrillation (35%). Over time, patients allocated to the vitamin K- guided strategy reached the prespecified INR more frequently so that after 90 days of follow-up, 74% were on target compared with 58% of patients managed conventionally (P = 0.04). Patients allocated to the dietary vitamin K- guided strategy had the same magnitude and direction of INR variation as those observed with the conventional approach in the short term (15 days) for both underanticaogulated and overanticoagulated patients. Minor bleeding or use of parenteral vitamin K were also marginally less frequent in patients managed according to the dietary intervention (1 [1.5%] versus 7 [11%]; P = 0.06). Conclusions-A vitamin K-guided management strategy to adjust long-term oral anticoagulation is feasible and safe and may result in an increased chance of reaching target levels of INR. (Circulation. 2009; 120: 1115-1122.)
引用
收藏
页码:1115 / U143
页数:11
相关论文
共 50 条
  • [1] Dietary vitamin K guidance: an effective strategy for stable control of oral anticoagulation?
    Booth, Sarah L.
    NUTRITION REVIEWS, 2010, 68 (03) : 178 - 181
  • [2] Dietary vitamin K intake and stability of anticoagulation with coumarins; evidence derived from a clinical trial
    Zuchinali, P.
    Souza, G. C.
    de Assis, M. C. S.
    Rabelo, E. R.
    Rohde, L. E.
    NUTRICION HOSPITALARIA, 2012, 27 (06) : 1987 - 1992
  • [3] Effect of 200 μG/day of vitamin k1 on the variability of anticoagulation control in patients on warfarin: A randomized controlled trial
    Majeed, Habeeb
    Rodger, Marc
    Forgie, Melissa
    Carrier, Marc
    Taljaard, Monica
    Scarvelis, Dimitrios
    Gonsalves, Carol
    Rodriguez, Rosendo A.
    Wells, Philip S.
    THROMBOSIS RESEARCH, 2013, 132 (03) : 329 - 335
  • [4] Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial
    Joosten, Linda P. T.
    van Doorn, Sander
    van de Ven, Peter M.
    Kohlen, Bart T. G.
    Nierman, Melchior C.
    Koek, Huiberdina L.
    Hemels, Martin E. W.
    Huisman, Menno V.
    Kruip, Marieke
    Faber, Laura M.
    Wiersma, Nynke M.
    Buding, Wim F.
    Fijnheer, Rob
    Adriaansen, Henk J.
    Roes, Kit C.
    Hoes, Arno W.
    Rutten, Frans H.
    Geersing, Geert-Jan
    CIRCULATION, 2024, 149 (04) : 279 - 289
  • [5] Vitamin K prophylaxis for preterm infants: A randomized, controlled trial of 3 regimens
    Clarke, Paul
    Mitchell, Simon J.
    Wynn, Robert
    Sundaram, Shanmuga
    Speed, Valerie
    Gardener, Elizabeth
    Roeves, Donna
    Shearer, Martin J.
    PEDIATRICS, 2006, 118 (06) : E1657 - E1666
  • [6] Wound healing effects of topical Vitamin K: A randomized controlled trial
    Pazyar, Nader
    Houshmand, Gholamreza
    Yaghoobi, Reza
    Hemmati, Ali Asghar
    Zeineli, Zahra
    Ghorbanzadeh, Behnam
    INDIAN JOURNAL OF PHARMACOLOGY, 2019, 51 (02) : 88 - 92
  • [7] Vitamin k1 versus vitamin K3 for prevention of subclinical vitamin deficiency:: A randomized controlled trial
    Chawla, D.
    Deorari, A. K.
    Saxena, R.
    Paul, V. K.
    Agarwal, R.
    Biswas, A.
    Meena, A.
    INDIAN PEDIATRICS, 2007, 44 (11) : 817 - 822
  • [8] Vitamin K1 in oral solution or tablets: a crossover trial and two randomized controlled trials to compare effects
    van Rein, N.
    Gebuis, E. P. A.
    Lijfering, W. M.
    Groeneveld, J. J. E.
    van der Horst, F. A. L.
    le Cessie, S.
    Rosendaal, F. R.
    van der Meer, F. J. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (12) : 2017 - 2023
  • [9] Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation
    Smith J.G.
    Newton-Cheh C.
    Current Cardiovascular Risk Reports, 2008, 2 (6) : 461 - 462
  • [10] Impact of genotype-guided dosing on anticoagulation visits for adults starting warfarin: a randomized controlled trial
    Jonas, Daniel E.
    Evans, James P.
    McLeod, Howard L.
    Brode, Shannon
    Lange, Leslie A.
    Young, Mary L.
    Shilliday, Betsy Bryant
    Bardsley, Michelle Martensen
    Swinton-Jenkins, Nia J.
    Weck, Karen E.
    PHARMACOGENOMICS, 2013, 14 (13) : 1593 - 1603